[Translation] A multicenter, randomized, open, parallel-controlled Phase III clinical trial comparing the efficacy and safety of semaglutide injection and Novotel® in the treatment of type 2 diabetes
主要目的:评价惠升生物制药股份有限公司的司美格鲁肽注射液与原研诺和泰®在2型糖尿病患者中的临床疗效。
次要目的:评价惠升生物制药股份有限公司的司美格鲁肽注射液与原研诺和泰®在2型糖尿病患者中的安全性。
[Translation] Primary objective: To evaluate the clinical efficacy of semaglutide injection of Huisheng Biopharmaceutical Co., Ltd. and the original Novotel® in patients with type 2 diabetes.
Secondary objective: To evaluate the safety of semaglutide injection of Huisheng Biopharmaceutical Co., Ltd. and the original Novotel® in patients with type 2 diabetes.